A Method for Treating Celiac Disease: Synthesis of Small Molecule Inhibitors of the HLA-DQ2 Receptor
CSEF · 2019 Biochemistry/ Molecular Biology First Award
Overview
Objectives My project aims to synthesize small molecules that prevent the HLA-DQ2 receptor from binding to alpha-2-gliadin proteins found in gluten, thus preventing the autoimmune response associated with Celiac Disease. Methods To synthesize my small molecule inhibitors, I developed a six-step synthesis that include a few different types of reactions such as: peptide coupling, heat-induced cyclization, Boc and Cbz protection and deprotection, and introduction of the alpha-keto sidechain derived from diethyl tartrate. Results Based on the data I have collected so far (proton NMR and TLC), my synthesis has been successful. I have also confirmed the identities of all of my intermediates throughout the process by interpreting the proton NMR data. This sets the stage for me to test the binding potential of my small molecule inhibitors on the HLA-DQ2 receptor. Conclusions I have successfully conducted my synthesis and I will send out purified samples of my small molecule inhibitors for binding assays at Stanford University Chemistry Department in the coming weeks. Those results will determine the effectiveness of my compound expanding the knowledge surrounding HLA-DQ2 Receptor inhibitors, and hopefully pave the way as an effective new treatment for Celiac patients. My work will hopefully lead to the synthesis of additional derivatives in an iterative fashion to ultimately discover a new class of compounds as therapeutics for patients with Celiac Disease.
Summary statement
I synthesized small molecule inhibitors that competitively inhibit the HLA-DQ2 receptor from binding to proteins found in gluten, thus preventing the autoimmune response associated with Celiac Disease that leads to inflammation.
Help received
I would discuss some of my reactions with my advisor, Mr. Darren Dressen, who would help me decide on which reactions were feasible. I also got some of my NMR data from Dr. David Brooks at SJSU, where I would send him my purified compounds and I would get back data to confirm it's identity.
Awards (1)
Competition history
- CSEF 2019
Resources
Related projects
ISEF · 2023
Model Validation and Preclinical Testing of Digestive Enzymes for Gluten Breakdown: A Move to Cure Gluten Intolerance and Celiac Disease
ISEF · 2024
Design, Synthesis, and Testing of Novel Small Molecule Interleukin-6 Inhibitors for the Amelioration of Inflammatory Bowel Disease
CSEF · 2006
Synthesis and Biological Evaluation of a Glycoprotein as Antibacterial Agent
CYSF · 2025
Designing an Immunoassay for Celiac Disease Detection In a Clinical Setting
ISEF · 2026
Design, Synthesis, and Testing of a Novel 3,5-Dimethoxycinnamic Acid-based Cathepsin C Inhibitor for the Treatment of Inflammatory Bowel Disease
CSEF · 2018
Synthesizing Inhibitors of Isocitrate Dehydrogenase 1 to Inhibit Glutamine-Dependent Reductive Carboxylation in Tumors
ISEF · 2022
Quantitative Methods To Analyze the Synergism of Digestive Enzymes for Gluten Breakdown: A Step Closer to Making Glu-Relief Pills
CSEF · 2010
In vitro Analysis of a Synthetic Protein: A Model for Enzyme Replacement Therapy
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects